CesarRodriguez ValdesMD

Hematology • New York, NY

Hematologic Oncology

Associate Professor, Clinical Director and Operations Myeloma Center of Excellence, Icahn School of Medicine at Mount Sinai

Join to view full profile

Dr. Rodriguez Valdes is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rodriguez Valdes' full profile

Already have an account?

Office
Icahn School of Medicine at Mount Sinai
1 Gustave L Levy Pl
New York, NY 10029
Phone+1 336-716-5847

Summary

.

Education & Training

University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 2009 - 2012
Texas Tech University Health Sciences Center Paul L. Foster School of MedicineResidency, 2006 - 2009
Monterrey Inst TechClass of 2005
ITESM MD

Certifications & Licensure

FL State Medical License 2022 - Present
NY State Medical License 2021 - 2026
NC State Medical License 2015 - 2021
KY State Medical License 2009 - 2016
American Board of Internal Medicine Hematology

Publications & Presentations

PubMed

International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma.
Luciano J Costa, Rahul Banerjee, Hira Mian, Katja Weisel, Susan Bal
Leukemia. 2025-01-27
MRD-negative duration following latest line of therapy predicts long-term PFS in real-world patients with multiple myeloma.
Lucia Y Chen, Santiago Thibaud, Saoirse Bodnar, Ajai Chari, Joshua Richter
Blood Advances. 2025-01-14
Delayed neutrophil recovery following BCMA CAR-T therapy in Duffy-null myeloma does not impact severe infections or survival.
Zachary M Avigan, Saoirse Bodnar, Darren Pan, Jerrel Catlett, Joshua Richter
Blood Advances. 2025-01-14